Affordable Prescriptions for Patients Act of 2024

The Affordable Prescriptions for Patients Act of 2024, also known as Bill 118 hr 9070, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to make prescription medications more affordable for patients across the country.

One key provision of the bill is the establishment of a Prescription Drug Affordability Board, which would be responsible for setting limits on the prices of certain prescription drugs. This board would work to ensure that patients are not being charged exorbitant prices for necessary medications.

Additionally, the Affordable Prescriptions for Patients Act of 2024 aims to increase transparency in the pharmaceutical industry. The bill would require drug manufacturers to disclose the costs associated with producing their medications, as well as any financial assistance programs that are available to patients. Furthermore, the legislation includes measures to promote competition in the prescription drug market. This includes provisions to prevent pharmaceutical companies from engaging in anti-competitive practices, such as pay-for-delay agreements. Overall, the Affordable Prescriptions for Patients Act of 2024 seeks to address the rising costs of prescription medications and make healthcare more affordable for all Americans. It is currently being debated in Congress, with supporters arguing that it will help lower drug prices and improve access to essential medications.